News/SEC filing/Aug 6, 2026, 4:13 PM ET

Gilead Sciences files quarterly report (10-Q) for the period ended Jun 30, 2026

Gilead SciencesGILD

Gilead Sciences filed its quarterly report on Form 10-Q with the SEC on Aug 6, 2026, 4:13 PM ET, covering the quarter ended Jun 30, 2026. It reports fiscal Q2 2026 results.

  • Revenue: $7.80B (+10.2% from $7.08B a year earlier)
  • Operating income: −$10.39B (vs $2.47B a year earlier)
  • Net income: −$10.50B (vs $1.96B a year earlier)
  • Diluted EPS: $-8.45 (vs $1.56 a year earlier)
  • Form 10-Q accepted by EDGAR Aug 6, 2026, 4:13 PM ET
  • Accession number 0000882095-26-000031
GILD around the story · hourly24 h reaction ▲ 2.51%
129.37132.79136.21Gilead Sciences files quarterly report (10-Q) for the period ended Jun 30, 20261Aug 2Aug 4Aug 6Aug 8Aug 10
Source
SEC EDGAR
Aug 6, 2026, 4:13 PM ET
Read the original ↗

SEC filing 10-Q · accession 0000882095-26-000031 · sec.gov ↗